| Identification | |
| Name: | Raltegravir |
| Synonyms: | N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide |
| CAS: | 518048-05-0;1100750-83-1 |
| Molecular Formula: | C20H21FN6O5 |
| Molecular Weight: | 444.4163 |
| InChI: | InChI=1/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30) |
| Molecular Structure: | ![(C20H21FN6O5) N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}...](https://img1.guidechem.com/dictimg/518048-05-0;1100750-83-1.jpg) |
| Properties | |
| Refractive index: | 1.65 |
| Safety Data | |
 |
|
